02269 藥明生物 WUXI BIO - 免費即時股票報價 - 股權披露變動 - etnet 經濟通|香港新聞財經資訊和生活平台

日期	股東名稱	披露原因	買入／賣出涉及的股份數目	每股平均價	持有權益的股份數目	佔已發行股本(%)
16/06/2023	周偉昌	1303(L)	52,735(L)		16,766,626(L)	0.39
16/06/2023	陳智勝	1303(L)	189,040(L)		120,813,435(L)	2.84
16/06/2023	Keller William Robert	1201(L)	-12(L)	HKD44.550(L)	21,899(L)	0.00
16/06/2023	Hitchner III Kenneth Walton	1201(L)	-12(L)	HKD44.550(L)	103,205(L)	0.00
15/06/2023	JPMorgan Chase & Co.	1101(L)	+1,851,980(L)	HKD46.339(L)	297,161,276(L) 23,087,837(S) 116,533,214(P)	7.02 0.54 2.75
14/06/2023	Keller William Robert	1302(L)	12(L)		21,911(L)	0.00
14/06/2023	Hitchner III Kenneth Walton	1302(L)	12(L)		103,217(L)	0.00
12/06/2023	Hitchner III Kenneth Walton	1303(L)	8,291(L)		103,217(L)	0.00
12/06/2023	Keller William Robert	1303(L)	4,145(L)		21,911(L)	0.00
09/06/2023	周偉昌	1201(L)	-42,486(L)	HKD44.453(L)	16,766,626(L)	0.39
09/06/2023	陳智勝	1201(L)	-292,407(L)	HKD44.453(L)	120,813,435(L)	2.84
07/06/2023	陳智勝	1302(L)	292,407(L)		121,105,842(L)	2.85
07/06/2023	周偉昌	1302(L)	42,486(L)		16,809,112(L)	0.40
05/06/2023	周偉昌	1303(L)	94,704(L)		16,809,112(L)	0.40
05/06/2023	陳智勝	1303(L)	591,900(L)		121,105,842(L)	2.85
02/06/2023	JPMorgan Chase & Co.	1201(L)	-3,727,295(L)	HKD43.935(L)	295,888,222(L) 24,933,000(S) 116,622,212(P)	6.99 0.58 2.75
16/05/2023	趙寧	1706(L)			584,191,133(L)	13.81
15/05/2023	JPMorgan Chase & Co.	11035(L)	+11,644,658(L)	HKD45.525(L)	298,833,856(L) 33,336,082(S) 115,310,659(P)	7.06 0.78 2.72
08/05/2023	JPMorgan Chase & Co.	16022(L)	-1,364,649(L)	HKD47.387(L)	295,551,787(L) 30,002,000(S) 115,753,908(P)	6.98 0.70 2.73
04/05/2023	JPMorgan Chase & Co.	11035(L)	+7,843,543(L)	HKD46.824(L)	298,112,531(L) 30,137,917(S) 117,280,572(P)	7.04 0.71 2.77
25/04/2023	JPMorgan Chase & Co.	1205(L)	-4,269,252(L)	HKD46.839(L)	293,044,688(L) 17,954,168(S) 115,312,816(P)	6.92 0.42 2.72
24/04/2023	JPMorgan Chase & Co.	1101(L)	+5,033,449(L)	HKD49.718(L)	297,313,940(L) 17,592,698(S) 117,098,817(P)	7.03 0.41 2.76
18/04/2023	JPMorgan Chase & Co.	1201(L)	-4,253,473(L)	HKD54.257(L)	295,880,953(L) 17,503,160(S) 113,015,962(P)	6.99 0.41 2.67
14/04/2023	JPMorgan Chase & Co.	1101(L)	+3,983,567(L)	HKD55.169(L)	299,727,302(L) 14,241,711(S) 108,193,422(P)	7.08 0.33 2.55
13/04/2023	JPMorgan Chase & Co.	1201(L)	-4,419,432(L)	HKD52.804(L)	295,743,735(L) 17,168,693(S) 107,371,672(P)	6.99 0.40 2.53
11/04/2023	JPMorgan Chase & Co.	1101(L)	+4,761,582(L)	HKD50.080(L)	298,860,787(L) 19,039,702(S) 106,179,422(P)	7.06 0.45 2.51
03/04/2023	JPMorgan Chase & Co.	1201(L)	-4,490,642(L)	HKD46.815(L)	291,567,262(L) 23,266,769(S) 105,036,979(P)	6.89 0.55 2.48
31/03/2023	JPMorgan Chase & Co.	1101(L)	+1,294,054(L)	HKD48.848(L)	296,057,904(L) 21,696,564(S) 104,444,354(P)	7.00 0.51 2.46
29/03/2023	JPMorgan Chase & Co.	16022(L)	-2,587,211(L)	HKD48.287(L)	295,227,200(L) 24,986,339(S) 104,829,854(P)	6.98 0.59 2.47
19/01/2023	WuXi Biologics Holdings Limited	1201(L)	-56,000,000(L)		584,191,133(L)	13.82
19/01/2023	張朝暉	1211(L)	-56,000,000(L)		584,191,133(L)	13.82
19/01/2023	New WuXi Life Science Holdings Limited	1201(L)	-56,000,000(L)		584,191,133(L)	13.82
19/01/2023	李革	1201(L)	-56,000,000(L)		584,191,133(L)	13.82
19/01/2023	WuXi PharmaTech (Cayman) Inc.	1201(L)	-56,000,000(L)		584,191,133(L)	13.82
19/01/2023	New WuXi Life Science Limited	1201(L)	-56,000,000(L)		584,191,133(L)	13.82
19/01/2023	劉曉鐘	1211(L)	-56,000,000(L)		584,191,133(L)	13.82
19/01/2023	趙寧	1201(L)	-56,000,000(L)		584,191,133(L)	13.82
16/01/2023	趙寧	1302(L)	56,000,000(L)		640,191,133(L)	15.14
16/01/2023	李革	1302(L)	56,000,000(L)		640,191,133(L)	15.14
13/01/2023	李革	1201(L)	-630,000(L)	HKD71.020(L)	640,191,133(L)	15.15

1 2 3 4 5

備註：	(L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
	(S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
	(P) - 可供借出的股份
	即時報價更新時間為 28/06/2024 18:00
	港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站

經濟通
強化版MQ
強化版TQ
財曆
Mobile
Web

客務熱線︰(852) 2880 7004 客務郵箱︰cs@etnet.com.hk
關於我們 | 產品服務 | 廣告查詢 | 聯絡我們 | 私隱政策 | 使用條款 | 網站導航 | 有用連結 | RSS新聞

Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.

《經濟通》所刊的署名及／或不署名文章，相關內容屬作者個人意見，並不代表《經濟通》立場，《經濟通》所扮演的角色是提供一個自由言論平台。